false --12-31 0001695473 0001695473 2026-07-29 2026-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED
STATES SECURITIES
AND EXCHANGE COMMISSION WASHINGTON,
D.C. 20549 FORM 8-K CURRENT
REPORT Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date
of Report (Date of earliest event reported): July 29, 2026 The
Greater Cannabis Company, Inc. (Exact
Name of Registrant as Specified in Charter) Florida 000-56027 30-0842570 (State
    of Other Jurisdiction (Commission
    File (IRS
    Employer Of
    Incorporation) Number) Identification
    No.) 200
    South Biscayne Blvd Fl 20 , Miami , FL 33131 (Address
    of Principal Executive Offices) (Zip
    Code) Registrant’s
telephone number, including area code: +52 1 55 6449 4966 (Former
Name or Former Address, if Changed Since Last Report) Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions: ☐ Written
    communications pursuant to Rule 425 under the Securities Act ☐ Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act ☐ Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On
July 29, 2026, the sole member of the Board of Directors (the “Board”) of The Greater Cannabis Company, Inc. (the “Company”)
approved, by unanimous written consent, the appointment of Carlos Septién, Michelle Cervantes Vivanco and Ernesto Gómez
Berjón as additional members of the Board of Directors of the Company. Pursuant to Section 14(f) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), and Rule 14f-1 promulgated thereunder, the appointments of such directors will
become effective upon the expiration of the ten (10) day period following the mailing of the Company’s Information Statement on
Schedule 14F-1 to its stockholders. Also
effective July 29, 2026, the Board appointed Carlos Septién as the Company’s Chief Operating Officer, Michelle Cervantes
Vivanco as the Company’s Chief Financial Officer, and Ernesto Gómez Berjón as the Company’s Chief Growth Officer.
Porfirio Sanchez Talavera will continue to serve as the Company’s Chief Executive Officer, Chairman of the Board, and director. The
appointments of the foregoing officers and directors were not made pursuant to any arrangement or understanding between any such person
and any other person, except in connection with the Company’s acquisition of control by Trafalgar Asset Management, LLC and the
Company’s ongoing strategic business combination initiatives. There are no family relationships among any of the Company’s
directors or executive officers. To
the knowledge of the Company, none of Carlos Septién, Michelle Cervantes Vivanco or Ernesto Gómez Berjón has, during
the past ten years, been involved in any legal proceeding required to be disclosed pursuant to Item 401(f) of Regulation S-K. Biographical
information regarding the newly appointed directors and executive officers is set forth below. Carlos
Septién, Director and Chief Operating Officer. Mr. Septién currently serves as Chief Executive Officer (Director General)
and Consejero Delegado of the Trafalgar group in Mexico, and was appointed Chief Operating Officer of the Company on July 29, 2026. He
has more than 45 years of executive experience in Mexican banking and financial services, including 35 years serving as chief executive
officer or vice president of banks and regulated financial institutions. From June 2021 to February 2024, Mr. Septién served as
Vice President and Chief Executive Officer of Banco Autofin México, and from March 2024 to August 2025 as Chief Executive Officer
of Grupo Diagnóstico Aries. Earlier in his career, he served as Chief Executive Officer of Laboratorios Médico El Chopo
(2015–2020) and of Grupo Libertad (2013–2014); as Chief Executive Officer of Grupo Elektra’s financial services operations
/ Banco Azteca (2002–2013), one of Mexico’s largest mass-market financial services platforms; as Deputy Chief Executive Officer
of Banorte (2002); as Chief Executive Officer and Chairman of the Board of Afore Bancrecer-Dresdner (2000–2001); as Chief Executive
Officer of Ixe Grupo Financiero (1996–2000); as Deputy Chief Executive Officer, Commercial and Consumer Banking, of Banco del Atlántico
(1992–1995); and in senior executive positions at BBVA México (1990–1992), Operadora de Bolsa (1989–1990) and
Banamex (1978–1989). Mr. Septién is a member of the board of directors of Sanfer-Invekra. He holds an Executive MBA from
Purdue University (1978) and a degree in Industrial Engineering from Universidad Iberoamericana (1975). Michelle
Cervantes Vivanco, Director and Chief Financial Officer. Ms. Cervantes Vivanco serves as Executive Vice President and Consejera Delegada
of the Trafalgar group in Mexico, and was appointed Chief Financial Officer of the Company on July 29, 2026. Since 2019, she has served
as chief financial officer across the group’s fintech ecosystem, with responsibility for the finances of a CNBV-regulated electronic
payment funds institution (IFPE) and of Trafalgar SFP, S.A. de C.V., S.F.P., a CNBV-licensed sociedad financiera popular, covering financial
planning, regulatory reporting and capital management. She is a member of the group’s Risk, Credit and Compensation committees.
Ms. Cervantes Vivanco has more than 20 years of experience in Mexican financial institutions, having served at Banorte from 2003 to 2016
and at BanBajío from 2016 to 2019, most recently as a Director. She holds a Master’s degree in Finance from Tecnológico
de Monterrey (2023), a licenciatura in Business Administration and Management from Universidad Nacional Autónoma de México
(2020), and a licenciatura in International Relations from Universidad Nacional Autónoma de México (2011). Ernesto
Gómez Berjón, Director and Chief Growth Officer. Mr. Gómez Berjón has served since 2026 as Chief Revenue
Officer of the Trafalgar group in Mexico, with a commercial mandate across Trafalgar SFP, S.A. de C.V., S.F.P. and TRF Casa de Bolsa,
and was appointed Chief Growth Officer of the Company on July 29, 2026. Since September 2021, he has served as Founder and Chief Executive
Officer of ERGO Capital (Intangilend México, S.A.P.I. de C.V.), a boutique advisory firm specializing in debt capital markets,
structured finance and institutional funding for non-bank lenders, fintech companies and SMEs, which serves as the exclusive Latin American
representative of Sivo, a U.S.-based debt capital platform for lenders. In that capacity, he has led the origination, structuring and
execution of debt facilities for fintech lenders across nine Latin American markets, institutional fundraising processes with global
private credit funds, the structuring of Mexican trust vehicles (fideicomisos), and credit portfolio analysis for institutional lenders,
and serves as a member of ERGO Capital’s credit committee. He previously served as Director of Operations (franchisee) of InFinance,
a franchise-based consumer and SME lending business (2018–2020); as Regional Manager for Mexico and Latin America of Genesis International
Ltd., a risk consulting and training firm for banks and financial institutions (2016–2018); as co-founder and Chief Executive Officer
of NeoTraining (2013–2020), which was acquired by AN Global Consulting in 2020; and as Chief Growth Officer and Director of Operations
of Finmex, a SOFOM, and OPORMEX, a CNBV-supervised SOFIPO, within the Grupo Dakab family office (2012–2015). Mr. Gómez Berjón
holds an MBA from Universidad Anáhuac and a bachelor’s degree from Universidad Panamericana. As
previously reported, Porfirio Sanchez Talavera currently serves as the Company’s Chief Executive Officer, Chairman of the Board
and sole director pending the effectiveness of the director appointments described above. Following the expiration of the Rule 14f-1
notice period, the Company’s Board of Directors will consist of Porfirio Sanchez Talavera, Carlos Septién, Michelle Cervantes
Vivanco and Ernesto Gómez Berjón. None
of the newly appointed officers or directors has entered into any material compensatory plan, contract or arrangement with the Company
in connection with such appointments, and none presently receives any salary, bonus, equity award or other compensation from the Company,
except as may be approved by the Board in the future. Item
5.03 – Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On
July 29, 2026, the Board of Directors of The Greater Cannabis Company, Inc. (the “Company”) approved, by unanimous written
consent, an amendment to the Company’s Articles of Incorporation providing for (i) a change of the Company’s name
from The Greater Cannabis Company, Inc. to Trafalgar International, Inc. and (ii) a one-for-five (1-for-5) reverse stock split of the Company’s issued and outstanding Common Stock (the “Reverse
Stock Split”), with any resulting fractional shares rounded up to the next whole share. The Reverse Stock Split applies only to the
Company’s Common Stock and does not affect the Company’s authorized Common Stock or Preferred Stock, or the outstanding shares, rights,
preferences or voting powers of any series of Preferred Stock. The Articles of Amendment will become effective upon filing
with the Florida Department of State or such later effective date as may be specified therein. In
connection with the Articles of Amendment, the Board also authorized management to submit the appropriate Corporate Action Notification
Form and supporting documentation to FINRA requesting implementation of the Company’s corporate name change, the one-for-five (1-for-5)
reverse stock split, and the corresponding trading symbol change. The corporate name change, reverse stock split and trading symbol change
will become effective following FINRA’s processing of the corporate action and completion of all applicable regulatory requirements. Also
on July 29, 2026, the Board approved and adopted Amended and Restated Bylaws of the Company, effective immediately. The Amended and Restated
Bylaws update and modernize the Company’s governance provisions and reflect the Company’s current management structure and
corporate governance practices. Copies
of the Articles of Amendment and the Amended and Restated Bylaws are filed as Exhibits 3.1 and 3.2 to this Current Report on Form 8-K
and are incorporated herein by reference. Item
8.01 Other Events On
July 29, 2026, the Board of Directors authorized the filing of an Information Statement on Schedule 14F-1 pursuant to Section 14(f) of
the Securities Exchange Act of 1934, as amended, and Rule 14f-1 promulgated thereunder, in connection with the appointment of Carlos
Septién, Michelle Cervantes Vivanco and Ernesto Gómez Berjón to the Company’s Board of Directors. The appointments
of such directors will become effective upon the expiration of the ten (10) day period following the mailing of the Information Statement
to the Company’s stockholders. The
Board also authorized the Company’s officers to take all actions necessary or desirable to implement the corporate actions approved by
the Board, including, without limitation, (i) filing Articles of Amendment with the Florida Department of State to effect the Company’s
corporate name change and one-for-five (1-for-5) reverse stock split; (ii) submitting the appropriate Corporate Action Notification Form
and related materials to FINRA in connection with the Company’s corporate name change, reverse stock split and trading symbol change;
and (iii) preparing, executing and filing such additional reports, notices and other documents with the Securities and Exchange Commission,
OTC Markets Group Inc., FINRA and other governmental or regulatory authorities as may be necessary or appropriate, and (iv) taking such
further actions as may be necessary or advisable to carry out the intent of the resolutions adopted by the Board. The
Company will announce the effective date of the corporate name change, one-for-five (1-for-5) reverse stock split and trading symbol
change following completion of the applicable regulatory processing. Item
9.01 Financial Statements and Exhibits (d)
Exhibits . 3.1 Articles of Amendment to the Articles of Incorporation providing for the corporate name change to Trafalgar International, Inc. and a one-for-five (1-for-5) reverse stock split of the Company’s Common Stock. 3.2 Amended and Restated Bylaws of Trafalgar International, Inc. 104 Cover
    Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. The Greater Cannabis Company, Inc. Date:
    July 30, 2026 By: /s/
    Porfirio Sanchez Talavera Porfirio
    Sanchez Talavera Chief
    Executive Officer

The Greater Cannabis Company appointed three new board members and executives on July 29, 2026: Carlos Septién as COO, Michelle Cervantes Vivanco as CFO, and Ernesto Gómez Berjón as Chief Growth Officer, effective after a ten-day stockholder notice period. This leadership restructuring signals the company's intent to strengthen management and accelerate growth operations.

On July 29, 2026, The Greater Cannabis Company, Inc. appointed Carlos Septién, Michelle Cervantes Vivanco, and Ernesto Gómez Berjón as new members of its Board of Directors. Their appointments are effective after a ten-day period following the mailing of the Information Statement to stockholders. Additionally, the Board named Carlos Septién as Chief Operating Officer, Michelle Cervantes Vivanco as Chief Financial Officer, and Ernesto Gómez Berjón as Chief Growth Officer, effective the same day. This restructuring aims to enhance leadership and drive growth within the company.

The Greater Cannabis Company, Inc.

AI Executive Summary

Key Takeaways

Raw Filing Content

Filing Overview

What This Means